Prot# M06-880: An Open-Label, Randomized, Phase 2 Study of Efficacy and Tolerability of ABT-869 in Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/9/08 → 10/8/09

Funding

  • Abbott Laboratories (Agmt 10/09/08)